Genetic Polymorphisms Associated With the Risk of Pancreatitis in Patients With Alcohol Related Cirrhosis.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-25

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alcohol is a known risk factor for both pancreatitis and cirrhosis. However, not all patients with alcohol related cirrhosis develop pancreatitis. It is not known which patients with alcohol-related cirrhosis develop symptomatic or clinically inapparent pancreatitis (Acute or Chronic Pancreatitis).There is no data whether genetic polymorphisms predispose patients with alcohol-related cirrhosis to additional pancreatic injury. There is no data on the spectrum of clinical and subclinical pancreatic changes (structural and functional) in patients with alcohol-related cirrhosis, and their genotypic correlates.This study aims to determine pancreatitis-related gene variants among patients with alcohol-related cirrhosis, with and without pancreatitis. We also aim to study differences in nutritional and functional parameters among alcoholic cirrhosis with and without chronic pancreatitis and also define the relationship of genetic polymorphisms with the pancreatic phenotype. Consecutive patients with alcohol related cirrhosis will be screened for changes of pancreatitis on CT/MR/EUS. Those with and without pancreatitis will be compared with respect to demographic, clinical, genotype, nutritional status .We will also be including a group of MAFLD/Cryptogenic cirrhosis for genotypic and phenotypic comparison.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations

NCT02928718

Acute Pancreatitis

COMPLETED

EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis

NCT04245189

Alcoholic Cirrhosis

UNKNOWN

Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis

NCT03083002

Carcinoma, Hepatocellular

UNKNOWN

Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis

NCT03566173

Acute Pancreatitis Nonalcoholic Fatty Liver Disease

COMPLETED

A Prospective Study of Natural History of Pancreatitis

NCT00685087

Chronic Pancreatitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim and Objective - To determine pancreatitis-related gene variants among patients with alcohol-related cirrhosis, with and without pancreatitis.

Primary objective: To determine the genetic variants associated with morphological and functional pancreatic changes among patients with alcohol-related cirrhosis.

Secondary objectives

1. To define the relationship of genetic polymorphisms with the pancreatic phenotype.\*
2. To study differences in nutritional and functional parameters among alcoholic cirrhosis with and without chronic pancreatitis.

Hypothesis -

\- Genetic polymorphisms related to pancreatitis predispose patients with alcohol-related cirrhosis to additional pancreatic injury.

Associated chronic pancreatitis (clinically apparent or subclinical) negatively influences the nutritional and functional status of patients with alcohol-related cirrhosis

* Study design: Cross sectional study of two study cohorts
* Study period: 1 year.
* Sample size with justification: Studies have reported pathogenic SPINK 1 mutations in 25% -50.0% among idiopathic CP and 10-20% in acute pancreatitis as compared to 1%-4.7% among controls. The investigator assume pathogenic SPINK 1 mutation frequency of 50% and 1% among alcohol-related cirrhosis with and without CP, respectively. The investigator also assume a 33% prevalence of CP among alcohol-related cirrhosis. With significance (α) at 0.5, power of 80%, investigator need to enroll 100 patients of alcohol-related cirrhosis.The investigator will also include a cohort of 50 males with cirrhosis of other etiologies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol-related Liver Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Alcohol-related cirrhosis

No interventions assigned to this group

Liver cirrhosis of other etiologies

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients \> 18 years of age.
2. Alcohol-related cirrhosis
3. Males

Exclusion Criteria

1. Current Hepatic encephalopathy or cognitive dysfunction precluding adequate nutritional and functional assessment.
2. HCC.
3. Complete or partial PVT.
4. Significant cardio-pulmonary comorbidity
5. Patients who do not consent for genetic study
6. Inability to provide informed consent.
7. Cannot understand Hindi or English should be excluded since they will not be able to reply objectively to questionnaire.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No